Angels for Change (A4C) successfully concluded its sold out SummitONE 2026, its annual healthcare summit focused on strengthening pharmaceutical supply chain resilience, at Pfizer's headquarters in New York City. The two-day event brought together executives and experts from across the pharmaceutical ecosystem; including manufacturers, distributors, healthcare systems, regulators, policymakers, and patient advocates. SummitONE advances collaboration and actionable solutions to strengthen access to medicines and end drug shortages.
Project GOLD is growing. Building on the success of its groundbreaking first phase, Angels for Change has launched Project GOLD Phase 2, expanding the nation's first collaborative initiative designed to protect cancer patients from drug shortages. With new manufacturer and distributor partners and an expanded portfolio of 15 high-risk oncology medicines, Phase 2 strengthens a proven model built on strategic U.S.-based buffer supply, early warning systems, and cross-sector collaboration. Following the successful protection of patient access during the national leucovorin shortage, Project GOLD continues to demonstrate that when industry leaders unite around a shared commitment to patients, together we can build a more resilient pharmaceutical supply chain and help ensure lifesaving cancer treatments remain available when patients need them most.
The newest Change Maker Chronicle is here! Drug shortages are still impacting patients every day, but together we are pushing forward. See how we’re raising awareness, fostering advocacy, and building resilent drug supply chains to end drug shortages NOW.
Angels for Change, through its Change Makers Institute, today announced the release of a new white paper, How Buffer Stock, Proactive Coordination, and Patient Advocacy Have Become a National Lifeline for Cancer Patients, highlighting the development and success of Project GOLD (Generic Oncology Lifesaving Drugs).
Angels for Change is proud to be a Member of the US Pharmacopeia Convention and part of their Drug Shortage Task Force. We support their call to action to solve drug shortages. Our work together is a movement for a total systemic shift in short and long-term solutions that will protect all patients in need of life-saving treatments.
TAMPA, Fla, February 1, 2024 - Laura Bray, founder and Chief Change Maker of patient advocacy group Angels for Change issued a statement on the new plan released by the Senate Finance Committee leadership on solutions for drug shortages
Last week, API Innovation Center released, "A Bold Goal: Reshoring 25% of Small Molecule API To The U.S. in 5 Years" white paper to the White House Office of Science and Technology. Angels for Change is proud to be a contributor on this important work and represent the patient perspective in solutions.
The Daily Mail and Alexa Lardieri covered the impact drug shortages are having on US patients and highlighted the Change Maker Movement.
"This is a patient problem," said Bray. "This is a national problem. This is a global problem. The supply chain is very brittle. It breaks every day and there is no extra. And then what happens is, patients are prioritized, and some people get it and some people don't. And it's not always clear why."
SHARE YOUR “WHY”
Every conversation, partnership, and shared story brings us closer to a future without drug shortages. At Angels for Change, we’re proud to march forth for patients everywhere.
